Cancer death rates fell 35% since 1991, and one Berkeley patient's inoperable brain tumor shrank 70% on an experimental drug. A new report credits research breakthroughs for the gains, then warns that over 2,200 frozen NIH grants and a proposed $5 billion cut could stall the next ones.

— via KQED, Steph Rodriguez